tirzepatide for diabetes Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the drug Mounjaro, has more tricks up its sleeve. Research out this week shows that it can do wonders Medscape - Continuing tirzepatide helped

adults dropped to 37 percent from a record 39.9 percent, according to a Gallup survey last year

These agents are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, based on findings from preclinical studies ( Treatment cessation should also be considered in patients who develop gallbladder complications, such as acute cholecystitis

Patients often have to learn to ignore a deeply ingrained, emotionally driven urge to eat as a reward for a job well done or to self-soothe after a difficult day something no drug can accomplish without indefinite use

Patients who had success on compounded GLP-1s should talk with their primary care providers or obesity medicine specialists, says Dr